<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01460992</url>
  </required_header>
  <id_info>
    <org_study_id>49</org_study_id>
    <nct_id>NCT01460992</nct_id>
  </id_info>
  <brief_title>ProMRI AFFIRM Study of the EVIA/ENTOVIS Pacemaker With Safio S Pacemaker Leads</brief_title>
  <acronym>ProMRIAFFIRM</acronym>
  <official_title>Master Study for the MRI Compatibility of the EVIA/ENTOVIS Pacemaker in Combination With Safio S Pacemaker Lead</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik SE &amp; Co. KG</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This investigation is designed to demonstrate the clinical safety of the EVIA/ ENTOVIS
      pacemaker system when used under specific MRI conditions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the past, MR scans were always contraindicated for pacemaker patients. If particular
      prerequisites and conditions are fulfilled, MR scans can now be conducted on patients with
      BIOTRONIK's EVIA/ENTOVIS pacemakers in combination with the Safio S pacemaker leads,
      scheduled to be part of this clinical study.

      The specific MRI conditions for this investigation with the EVIA/ENTOVIS pacemaker family and
      Safio S pacemaker leads are defined in the study protocol
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Primary hypothesis 1: MRI and pacing system related Serious Adverse Device Effect (SADE) free rate</measure>
    <time_frame>3 months</time_frame>
    <description>MRI and pacing system related Serious Adverse Device Effect (SADE) Free-Rate is greater than 90%.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary hypotheses 2 and 3: pacing threshold rise (atrial and ventricular)</measure>
    <time_frame>1 month</time_frame>
    <description>The atrial or ventricular MRI induced pacing threshold rise is not larger than or equal to 0.5 V between Pre-MRI and 1-month follow-up</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary hypothesis 4: P-wave sensing attenuation</measure>
    <time_frame>1 month</time_frame>
    <description>P-wave attenuation: P-wave amplitude decrease (between pre-MRI follow-up and 1-month follow-up) exceeding 50% or a P-wave amplitude at 1-month follow-up smaller or equal to 1.5 mV</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary hypothesis 5: R-wave sensing attenuation</measure>
    <time_frame>1 month</time_frame>
    <description>R-wave attenuation: R-wave amplitude decrease (between pre-MRI follow-up and 1-month follow-up) exceeding 50% or a R-wave amplitude at 1-month follow-up smaller or equal to 5.0 mV.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">121</enrollment>
  <condition>Cardiac Disease</condition>
  <arm_group>
    <arm_group_label>Pacemaker therapy</arm_group_label>
    <description>Patients with an EVIA/ ENTOVIS pacemaker device. See inclusion and exclusion criteria.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Evia/Entovis pacemaker system under Magnetic Resonance Imaging (MRI) conditions</intervention_name>
    <description>patients will undergo an MRI scan for 30 minutes.</description>
    <arm_group_label>Pacemaker therapy</arm_group_label>
    <other_name>Evia/Entovis SR-T (single chamber with telemetry function), DR-T (dual chamber with telemetry function)</other_name>
    <other_name>Atrial/ventricular lead(s): Safio S 53 and S 60.</other_name>
    <other_name>Safio S 45</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The patients selected for participation should be from the investigator's general patient
        population according to the inclusion and exclusion criteria.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pacemaker system consisting solely of the EVIA/ENTOVIS pacemaker and Safio S pacemaker
             leads

          -  The pacemaker system has to be implanted, repositioned or exchanged at least 5 weeks
             prior to enrollment

          -  Age more than 18 years

          -  Understand the nature of the procedure

          -  Able and willing to complete MRI testing

          -  Able and willing to activate and use the Cardio Messenger

          -  Give written informed consent

          -  Able to complete all testing required by the clinical protocol

          -  Ability to measure atrial and/or ventricular pacing threshold(s)* (at 0.4 ms)

          -  All pacing thresholds do not exceed 2.0V @0.4ms.

          -  Available for follow-up visit at the investigational site

          -  Patient body height greater or equal to 140 cm

          -  Pectoral implantation

          -  The ascertained lead impedance is between 200 and 1500 Ohms.

        Exclusion Criteria:

          -  No EVIA/ENTOVIS /Safio S pacemaker system implanted

          -  Pacing threshold(s) (at 0.4 ms) and sensing amplitudes are not measurable

          -  Meet one or more of the contraindications

          -  Being pregnant

          -  Have a life expectancy of less than three months

          -  Cardiac surgery already scheduled in the next three months

          -  Enrolled in another cardiac clinical investigation

          -  Have other medical implants that may interact with MRI, e.g. abandoned pacemaker/ICD
             leads, lead extensions, other active medical devices, non-MRI compatible devices (e.g.
             mechanical tricuspid valve)

          -  Have other metallic artifacts/components in body that may interact with MRI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aldo Rinaldi, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cardiology Department, St Thomas' Hospital Lambeth Palace Road London, SE1 7EH United Kingdom E-mail: Aldo.Rinaldi@gstt.nhs.uk</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Allgemeines Krankenhaus Linz</name>
      <address>
        <city>Linz</city>
        <zip>4021</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Olomouc</name>
      <address>
        <city>Olomouc</city>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Gertrauden Krankenhaus</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Städtisches Klinikum Dresden-Friedrichstadt</name>
      <address>
        <city>Dresden</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Uniklinik Leipzig</name>
      <address>
        <city>Leipzig</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diakoniekrankenhaus Mannheim</name>
      <address>
        <city>Mannheim</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>DRK Krankenhaus Neuwied</name>
      <address>
        <city>Neuwied</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stadtspital Triemli</name>
      <address>
        <city>Zürich</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Department, St Thomas' Hospital</name>
      <address>
        <city>London</city>
        <zip>SE1 7EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Czech Republic</country>
    <country>Germany</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 24, 2011</study_first_submitted>
  <study_first_submitted_qc>October 26, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 27, 2011</study_first_posted>
  <last_update_submitted>November 27, 2013</last_update_submitted>
  <last_update_submitted_qc>November 27, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 28, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pacemaker therapy</keyword>
  <keyword>Magnetic Resonance Imaging (MRI)</keyword>
  <keyword>EVIA/ENTOVIS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

